2025
SJR Q2
JCR Q2 · 4
532 matched articles
SCIE
Journal detail
Naunyn-Schmiedeberg's Archives of Pharmacology
- Publisher
- Springer Science and Business Media Deutschland GmbH
- Country
- Germany · Western Europe
- Type
- journal
- ISSN
-
0028129814321912
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,877
- Quartile Q2
- H-Index 104
- Cites/doc 4,73
- Docs (3y) 1.044
- Cites (3y) 4.915
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 4
- 5Y JIF 3,8
- JCI 0,79
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Medicine (miscellaneous) Q2
- Pharmacology Q2
Areas
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,877 | 4 | 3,8 | 0,79 | Q2 | 104 |
| 2024 | Q2 | Q2 | 0,768 | 3,1 | 3,1 | 0,78 | Q2 | 101 |
| 2023 | Q2 | Q2 | 0,735 | 3,1 | 3,1 | 0,9 | Q2 | 101 |
| 2022 | Q2 | Q2 | 0,66 | 3,6 | 3,2 | 0,88 | Q2 | 101 |
| 2021 | Q2 | Q3 | 0,566 | 3,2 | 3 | 0,82 | Q2 | 101 |
| 2020 | Q2 | Q3 | 0,67 | 3 | 2,6 | 0,77 | Q2 | 101 |
| 2019 | Q2 | Q3 | 0,614 | 2 | 2,1 | 0,76 | Q2 | 101 |
| 2018 | — | Q3 | — | 2,1 | 2,2 | 0,77 | Q2 | — |
| 2017 | Q2 | Q3 | 0,836 | 2,2 | 2,1 | 0,87 | Q2 | 101 |
| 2016 | Q2 | Q2 | 0,814 | 2,6 | 2,3 | — | — | 101 |
| 2015 | Q2 | Q2 | 0,867 | 2,4 | 2,2 | — | — | 101 |
| 2014 | Q1 | Q2 | 0,9 | 2,5 | 2,3 | — | — | 101 |
| 2013 | Q1 | Q2 | 0,869 | 2,4 | 2,4 | — | — | 101 |
| 2012 | Q1 | Q3 | 0,876 | 2,1 | 2,2 | — | — | 101 |
| 2011 | Q1 | Q2 | 1,033 | 2,6 | 2,6 | — | — | 101 |
| 2010 | Q1 | Q2 | 1,054 | 2,5 | 2,4 | — | — | 101 |
| 2009 | — | Q2 | — | 2,6 | 2,6 | — | — | — |
| 2008 | — | Q2 | — | 2,8 | 2,4 | — | — | — |
| 2007 | — | Q2 | — | 2,2 | 2,1 | — | — | — |
| 2006 | — | Q2 | — | 2,8 | — | — | — | — |
| 2005 | — | Q2 | — | 2,1 | — | — | — | — |
| 2004 | — | Q2 | — | 2 | — | — | — | — |
| 2003 | — | Q2 | — | 2,1 | — | — | — | — |
| 2002 | — | Q1 | — | 2,6 | — | — | — | — |
| 2001 | — | Q1 | — | 2,5 | — | — | — | — |
| 2000 | — | Q1 | — | 2,9 | — | — | — | — |
| 1999 | — | Q1 | — | 2,4 | — | — | — | — |
| 1998 | — | Q1 | — | 2,2 | — | — | — | — |
| 1997 | — | Q1 | — | 2,5 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 109/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 134/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 126/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 114/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 168/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 166/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 193/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 176/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 154/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 120/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 125/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 119/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 120/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 135/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 101/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 110/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 97/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 74/219 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 99/205 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 59/199 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 81/193 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 83/187 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 66/185 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 45/188 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 40/186 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 28/181 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 35/175 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 31/178 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 23/157 |